Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

[1]  V. Dixit,et al.  Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.

[2]  J. Folkman.  Angiogenesis and breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[4]  J. Folkman,et al.  Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. , 1994, Microvascular research.

[5]  K. Nagata,et al.  Microglia‐Derived Elastase Produces a Low‐Molecular‐Weight Plasminogen that Enhances Neurite Outgrowth in Rat Neocortical Explant Cultures , 1993, Journal of neurochemistry.

[6]  J. Martial,et al.  The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. , 1993, Endocrinology.

[7]  R. Prehn.  Two competing influences that may explain concomitant tumor resistance. , 1993, Cancer research.

[8]  O. Volpert,et al.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity , 1993, The Journal of cell biology.

[9]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[10]  A. Wyllie,et al.  Apoptosis (the 1992 Frank Rose Memorial Lecture). , 1993, British Journal of Cancer.

[11]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[12]  C. Ponting,et al.  Plasminogen: a structural review. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  L. Weissbach,et al.  A plasminogen-related gene is expressed in cancer cells. , 1992, Biochemical and biophysical research communications.

[14]  W. Richardson,et al.  Cell death and control of cell survival in the oligodendrocyte lineage , 1992, Cell.

[15]  A. Ichinose.  Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. , 1992, Biochemistry.

[16]  R. Sasada,et al.  Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. , 1991, Cancer research.

[17]  M. Iruela-Arispe,et al.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Prochownik,et al.  Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. , 1991, The Journal of clinical investigation.

[19]  S. Schreiber,et al.  Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus , 1991, Journal of protein chemistry.

[20]  R T Prehn,et al.  The inhibition of tumor growth by tumor mass. , 1991, Cancer research.

[21]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[22]  R. Ruggiero,et al.  Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors. , 1990, Cancer research.

[23]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Auerbach,et al.  A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[25]  W. Owen,et al.  Neutrophil proteases in plasminogen activation. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[26]  W. Bursch,et al.  Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. , 1990, Carcinogenesis.

[27]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[28]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[29]  W. Owen,et al.  An elastase-dependent pathway of plasminogen activation. , 1989, Biochemistry.

[30]  N Gunduz,et al.  Presence of a growth-stimulating factor in serum following primary tumor removal in mice. , 1989, Cancer research.

[31]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[32]  R. Ruggiero,et al.  Role of concomitant resistance in the development of murine lung metastases , 1988, International journal of cancer.

[33]  J. Williams,et al.  Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. , 1985, The American journal of pathology.

[34]  W. Mangel,et al.  Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin. , 1985, Biochemistry.

[35]  R. Ruggiero,et al.  "Concomitant immunity" in murine tumours of non-detectable immunogenicity. , 1985, British Journal of Cancer.

[36]  N Gunduz,et al.  Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.

[37]  E. Gorelik.  Concomitant tumor immunity and the resistance to a second tumor challenge. , 1983, Advances in cancer research.

[38]  E. Gorelik.  Resistance of tumor-bearing mice to a second tumor challenge. , 1983, Cancer research.

[39]  Michael Feldman,et al.  On the mechanism of tumor ‘concomitant immunity’ , 1981, International journal of cancer.

[40]  S. Segal,et al.  Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity. , 1980, Journal of the National Cancer Institute.

[41]  P. Lerch,et al.  Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. , 1980, European journal of biochemistry.

[42]  Mayo,et al.  Accelerated growth of testicular cancer after cytoreductive surgery , 1980 .

[43]  J. Folkman,et al.  Long-term culture of capillary endothelial cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N Gunduz,et al.  Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.

[45]  R. Auerbach,et al.  Angiogenesis in the mouse cornea. , 1979, Science.

[46]  Michael Feldman,et al.  GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES , 1978, International journal of cancer.

[47]  E. Schöpf,et al.  Inhibition of DNA synthesis by a factor from ascites tumor cells. , 1977, European journal of cancer.

[48]  C. Elleman,et al.  Suppressive factors in ascitic fluids and sera of mice bearing ascites tumors. , 1977, Journal of the National Cancer Institute.

[49]  L Simpson-Herren,et al.  Effects of surgery on the cell kinetics of residual tumor. , 1976, Cancer treatment reports.

[50]  J. Yuhas,et al.  Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. , 1974, Cancer research.

[51]  H. Withers,et al.  Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. , 1974, Cancer research.

[52]  W. Dewys.  Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. , 1972, Cancer research.

[53]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[54]  P. Bichel.  Autoregulation of ascites tumour growth by inhibition of the G-1 and the G-2 phase. , 1971, European journal of cancer.

[55]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[56]  D. Rounds.  A growth-modifying factor from cell lines of human malignant origin. , 1970, Cancer research.

[57]  F. Rapp,et al.  Concomitant immunity in hamsters bearing dmba‐induced tumor transplants , 1969, International journal of cancer.

[58]  V. Kinzel,et al.  Chalones and Cancer: Melanoma Regression induced by “Chalone”: a New Tumour Inhibiting Principle acting in vivo , 1968, Nature.

[59]  R. Gershon,et al.  On Concomitant Immunity in Tumour-bearing Hamsters , 1967, Nature.

[60]  Howard Jm.  STUDIES OF AUTOTRANSPLANTATION OF INCURABLE CANCER. , 1963 .

[61]  G. Moore,et al.  Heterologous, homologous, and autologous transplantation of human tumors , 1963, Cancer.

[62]  C. Southam,et al.  Quantitative studies of autotransplantation of human cancer. Preliminary report , 1961 .

[63]  C. Southam,et al.  QUANTITATIVE STUDIES OF AUTOTRANSPLANTATION OF HUMAN CANCER , 1961 .

[64]  H. Greene,et al.  The inhibitory influence of a transplanted hamster lymphoma on metastasis. , 1960, Cancer research.

[65]  W. Schatten.  An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor , 1958, Cancer.

[66]  Tyzzer Ee,et al.  Factors in the Production and Growth of tumor Metastases. , 1913 .

[67]  E. F. Bashford,et al.  The Natural and Induced Resistance of Mice to the Growth of Cancer , 1907 .